Category: Hot News

Pfizer Halts Obesity Pill Development

` tags: “`xml Pfizer is halting the development of its experimental once-a-day obesity pill, even after starting extensive and costly clinical trials. The pharmaceutical company announced on Tuesday that it will discontinue studies on danuglipron due to a trial participant

More